• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

瑞士大疱性类天疱疮死亡率:一项前瞻性研究。

Mortality of bullous pemphigoid in Switzerland: a prospective study.

机构信息

Service de Dermatologie, Hôpitaux Universitaires de Genève, 1211 Geneva 14, Switzerland.

出版信息

Br J Dermatol. 2011 Aug;165(2):368-74. doi: 10.1111/j.1365-2133.2011.10413.x.

DOI:10.1111/j.1365-2133.2011.10413.x
PMID:21574978
Abstract

BACKGROUND

Bullous pemphigoid (BP) is the most common autoimmune subepidermal blistering disease of the skin and has been associated with a significant morbidity and an increased mortality rate.

OBJECTIVES

Our aims were: (i) to evaluate the mortality rate of BP in Swiss patients during the first 3 years after the diagnosis of BP, as the primary endpoint; and (ii) to compare this mortality rate with that of the general Swiss population and determine prognostics factors, as secondary endpoints.

METHODS

All new cases of BP diagnosed in Switzerland between 1 January 2001 and 31 December 2002 were collected prospectively by means of a standardized data collection form. After collection of the data, the treating physicians were asked to specify the course and evolution of the disease. In total, 115 patients were included in our study.

RESULTS

The 1-, 2- and 3-year probability of death were 20·9%, 28·0% and 38·8%, respectively. The mortality rate of patients with BP was three times higher than that of age- and sex-matched members of the general Swiss population. Besides age, the presence of neurological diseases at diagnosis was associated with increased mortality in multivariate analysis.

CONCLUSION

This is the first prospective study analysing the mortality rate of BP in an entire country. The calculated mortalities are in the lower range of those reported in previous European studies. However, in line with the latter, our findings confirm a high case-fatality rate for BP, with an increased 1-year mortality rate compared with the expected mortality rate for age- and sex-adjusted general population.

摘要

背景

大疱性类天疱疮(BP)是皮肤最常见的自身免疫性表皮下水疱病,与较高的发病率和死亡率相关。

目的

我们的目的是:(i)评估瑞士患者在诊断为 BP 后的前 3 年内的 BP 死亡率,作为主要终点;(ii)将该死亡率与瑞士一般人群的死亡率进行比较,并确定次要终点预后因素。

方法

通过标准化数据收集表,前瞻性地收集了 2001 年 1 月 1 日至 2002 年 12 月 31 日期间在瑞士诊断的所有新 BP 病例。收集数据后,要求治疗医生指定疾病的过程和演变。共有 115 例患者纳入本研究。

结果

1、2、3 年的死亡率分别为 20.9%、28.0%和 38.8%。BP 患者的死亡率是年龄和性别匹配的瑞士一般人群的三倍。除了年龄外,在多变量分析中,诊断时存在神经疾病与死亡率增加相关。

结论

这是第一项在整个国家分析 BP 死亡率的前瞻性研究。计算出的死亡率处于以前欧洲研究报告的较低范围。然而,与后者一致,我们的研究结果证实了 BP 的高病死率,与年龄和性别调整后的一般人群的预期死亡率相比,1 年死亡率增加。

相似文献

1
Mortality of bullous pemphigoid in Switzerland: a prospective study.瑞士大疱性类天疱疮死亡率:一项前瞻性研究。
Br J Dermatol. 2011 Aug;165(2):368-74. doi: 10.1111/j.1365-2133.2011.10413.x.
2
Incidence of bullous pemphigoid and pemphigus in Switzerland: a 2-year prospective study.瑞士大疱性类天疱疮和天疱疮的发病率:一项为期 2 年的前瞻性研究。
Br J Dermatol. 2009 Oct;161(4):861-8. doi: 10.1111/j.1365-2133.2009.09300.x. Epub 2009 May 8.
3
Mortality rate in bullous pemphigoid: a retrospective monocentric cohort study.大疱性类天疱疮的死亡率:一项回顾性单中心队列研究。
Dermatology. 2012;225(4):320-5. doi: 10.1159/000345625. Epub 2012 Dec 21.
4
Clinical presentation and diagnostic delay in bullous pemphigoid: a prospective nationwide cohort.大疱性类天疱疮的临床表现和诊断延迟:一项前瞻性全国性队列研究。
Br J Dermatol. 2012 Nov;167(5):1111-7. doi: 10.1111/j.1365-2133.2012.11108.x.
5
Mortality of bullous pemphigoid: an evaluation of 223 patients and comparison with the mortality in the general population in the United States.大疱性类天疱疮的死亡率:223例患者的评估及与美国普通人群死亡率的比较
J Am Acad Dermatol. 2008 Oct;59(4):582-8. doi: 10.1016/j.jaad.2008.07.022. Epub 2008 Aug 15.
6
Annual incidence and mortality of bullous pemphigoid in the Grampian Region of North-east Scotland.苏格兰东北部格兰扁地区大疱性类天疱疮的年发病率和死亡率。
Br J Dermatol. 2005 Aug;153(2):424-7. doi: 10.1111/j.1365-2133.2005.06662.x.
7
Mortality of patients with bullous pemphigoid in Korea.韩国大疱性类天疱疮患者的死亡率。
J Am Acad Dermatol. 2014 Oct;71(4):676-83. doi: 10.1016/j.jaad.2014.05.006. Epub 2014 Jun 12.
8
Prediction of survival for patients with bullous pemphigoid: a prospective study.大疱性类天疱疮患者生存情况的预测:一项前瞻性研究。
Arch Dermatol. 2005 Jun;141(6):691-8. doi: 10.1001/archderm.141.6.691.
9
Anti-BP180 autoantibodies as a marker of poor prognosis in bullous pemphigoid: a cohort analysis of 94 elderly patients.抗BP180自身抗体作为大疱性类天疱疮预后不良的标志物:94例老年患者的队列分析
Br J Dermatol. 1997 May;136(5):694-8.
10
[One year follow-up of patients with bullous pemphigoid].大疱性类天疱疮患者的一年随访
Ann Dermatol Venereol. 2009 May;136(5):407-11. doi: 10.1016/j.annder.2009.01.009. Epub 2009 Apr 23.

引用本文的文献

1
Pemphigoid disease model systems for clinical translation.用于临床转化的类天疱疮疾病模型系统
Front Immunol. 2025 Mar 17;16:1537428. doi: 10.3389/fimmu.2025.1537428. eCollection 2025.
2
Chronic disease associated with bullous pemphigoid risk: A systematic review and meta-analysis.与大疱性类天疱疮风险相关的慢性病:一项系统评价和荟萃分析。
JAAD Int. 2024 Sep 7;17:141-152. doi: 10.1016/j.jdin.2024.08.010. eCollection 2024 Dec.
3
Retrospective analysis of autoimmune bullous diseases in Middle Franconia.回顾性分析中弗兰肯地区的自身免疫性大疱性皮肤病。
Front Immunol. 2023 Oct 10;14:1256617. doi: 10.3389/fimmu.2023.1256617. eCollection 2023.
4
Janus kinase inhibitors in autoimmune bullous diseases.自身免疫性大疱性疾病的 Janus 激酶抑制剂。
Front Immunol. 2023 Jul 10;14:1220887. doi: 10.3389/fimmu.2023.1220887. eCollection 2023.
5
Effect of early initiation of steroid-sparing drugs in patients with bullous pemphigoid.大疱性类天疱疮患者中早期起始应用皮质类固醇激素节省药物的效果。
Front Immunol. 2023 Jul 6;14:1176284. doi: 10.3389/fimmu.2023.1176284. eCollection 2023.
6
Risk of Serious Infections in Patients with Bullous Pemphigoid: A Population-based Cohort Study.大疱性类天疱疮患者发生严重感染的风险:一项基于人群的队列研究。
Acta Derm Venereol. 2023 Jun 5;103:adv5329. doi: 10.2340/actadv.v103.5329.
7
Insights Into the Pathogenesis of Bullous Pemphigoid: The Role of Complement-Independent Mechanisms.大疱性类天疱疮发病机制的研究进展:补体非依赖机制的作用。
Front Immunol. 2022 Jul 7;13:912876. doi: 10.3389/fimmu.2022.912876. eCollection 2022.
8
How Do Experts Treat Patients with Bullous Pemphigoid around the World? An International Survey.世界各地的专家如何治疗大疱性类天疱疮患者?一项国际调查。
JID Innov. 2022 Apr 12;2(4):100129. doi: 10.1016/j.xjidi.2022.100129. eCollection 2022 Jul.
9
Clinical Effectiveness and Safety of Initial Combination Therapy with Corticosteroids and Rituximab in Bullous Pemphigoid: A Retrospective Cohort Study.大疱性类天疱疮初始激素联合利妥昔单抗治疗的临床疗效及安全性:一项回顾性队列研究。
Am J Clin Dermatol. 2022 Jul;23(4):571-585. doi: 10.1007/s40257-022-00688-x. Epub 2022 May 17.
10
Prognostic factors for mortality in bullous pemphigoid: A systematic review and meta-analysis.大疱性类天疱疮病死率的预后因素:系统评价和荟萃分析。
PLoS One. 2022 Apr 15;17(4):e0264705. doi: 10.1371/journal.pone.0264705. eCollection 2022.